# Comprehensive Assessment of Cancer Theranostic Response

> **NCT06815354** · NA · RECRUITING · sponsor: **AIQ Solutions** · enrollment: 32 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DEVICE:** TRAQinform Theranostics

## Key facts

- **NCT ID:** NCT06815354
- **Lead sponsor:** AIQ Solutions
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-02
- **Primary completion:** 2026-03-30
- **Final completion:** 2026-05-29
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2025-09-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06815354

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06815354, "Comprehensive Assessment of Cancer Theranostic Response". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06815354. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*